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Exocrine tissue-driven TFF2 
prevents apoptotic cell death of 
endocrine lineage during pancreas 
organogenesis
Koji Hirata1,2, Sota Kodama1,2, Yasuhiro Nakano2, Yasuko Minaki-Nakagawa2, 
Yoshiki Aoyama1,2, Morito sakikubo1,2, Toshihiko Goto1,2, Masahiro Yoshida1,2, 
toshihiko Masui1, Takuya Yamamoto3, Shinji Uemoto1 & Yoshiya Kawaguchi2
During embryogenesis, exocrine and endocrine pancreatic tissues are formed in distinct regions within 
the branched ductal structure in mice. We previously reported that exocrine-specific inactivation of 
Pdx1 by elastase-Cre caused not only hypoplastic exocrine formation but also substantial endocrine 
defects resulting in diabetic phenotype, indicating the existence of an exocrine-driven factor(s) that 
regulates proper endocrine development. In this study, we identified Trefoil Factor 2 (TFF2) as an 
exocrine gene expressed from embryonic day 16.5 to adulthood in normal mice but significantly less in 
our Pdx1 mutants. Using in vitro explant culture of embryonic pancreatic tissue, we demonstrated that 
TFF2 prevented the apoptosis of insulin-producing cells but that antagonizing CXCR4, a known TFF2 
receptor, suppressed this anti-apoptotic effect in the mutants. Furthermore, the antagonist in normal 
pancreatic tissue accelerated the apoptosis of insulin-producing cells, indicating that the TFF2/CXCR4 
axis maintains embryonic insulin-producing cells in normal development. TFF2 also suppressed the 
apoptosis of Nkx6.1+ endocrine precursors in mutant pancreata, but this effect was unperturbed by the 
CXCR4 antagonist, suggesting the existence of an unknown receptor for TFF2. These findings suggest 
TFF2 is a novel exocrine factor that supports the survival of endocrine cells in the multiple stages of 
organogenesis through distinct receptors.
The adult pancreas plays two roles. One is exocrine function, in which acinar cells secrete digestive enzymes 
into the duodenum. The other is endocrine function, in which islets secrete hormones into the bloodstream to 
maintain blood glucose homeostasis. During embryonic organogenesis, both exocrine and endocrine pancreatic 
tissues originate from the pancreatic buds. Within the pancreatic buds, epithelial cells gradually form the ductal 
plexus and undergo remodeling to form a branched duct structure composed of a CPA- and Ptf1a-expressing tip 
domain and a Nkx6.1-positive trunk domain1. During segregation of the tip/trunk regions, the differentiation 
ability of epithelial cells is spatiotemporally regulated; Pdx1+Ptf1a+cMychighCpa1+ progenitor cells are multipo-
tent at first but lose their ability for endocrine differentiation after E13-14, whereas Nkx6.1+ cells in the trunk 
region can differentiate into endocrine and duct cells1,2. In endocrine lineage, Ngn3+ endocrine precursor cells 
bud out from the lining of the Nkx6.1+ ductal trunk and differentiate into all cell types of the islet, including 
glucagon+ α cells, insulin+ β cells, somatostatin+ δ cells and pancreatic polypeptide+ PP cells.
The necessity of exocrine tissue formation for proper endocrine development was assessed in our previous 
study by using Elastase-Cre;Pdx1loxP/loxP (Pdx1cKO) mice, in which Pancreatic and duodenal homeobox 1 (Pdx1), 
an indispensable gene for pancreas organogenesis, can be inactivated specifically in exocrine tissue. We demon-
strated that the mutant mice not only showed hypoplastic formation of exocrine tissue, but also severe endocrine 
defects during embryogenesis characterized by accelerated apoptosis in the trunk region leading to reduced num-
bers of Nkx6.1+ cells, Ngn3+ endocrine precursors and Insulin+ cells at embryonic day 14.5 (E14.5). Moreover, 
the postnatal expansion of endocrine cells was extremely poor in the mutants, resulting in glucose intolerance at 
1Department of Hepato-Biliary-Pancreatic Surgery and Transplantation, Kyoto University Graduate School 
of Medicine, Kyoto, Japan. 2Department of Clinical Application, Center for iPS cell Research and Application, 
Kyoto, Japan. 3Department of Life Science Frontiers, Center for iPS Cell Research and Application, Kyoto, Japan. 
Correspondence and requests for materials should be addressed to Y.K. (email: yoshiyak@cira.kyoto-u.ac.jp)
Received: 6 September 2018
Accepted: 19 December 2018
Published: xx xx xxxx
opeN
www.nature.com/scientificreports/
2Scientific RepoRts |          (2019) 9:1636  | https://doi.org/10.1038/s41598-018-38062-9
postnatal day 28 (P28). These observations suggested the existence of essential factors in the exocrine tissue that 
regulate proper development and proper function at multiple differentiation steps of endocrine lineage3.
In the present study, we aimed to identify the responsible factor(s). We performed microarray analyses and 
identified Trefoil Factor 2 (TFF2) as an exocrine factor in embryonic and adult pancreas in normal mice, but 
found its expression was extremely low in Pdx1cKO mice. Our explant culture experiments using embryonic 
pancreatic tissue demonstrated that TFF2 functions to protect endocrine cells against apoptosis at multiple dif-
ferentiation stages including Nkx6.1+ endocrine progenitors and Insulin+ cells. These findings suggest TFF2 
is a novel exocrine factor that acts as a paracrine signal and is required for proper endocrine formation during 
pancreas organogenesis.
Results
TFF2 is expressed in pancreatic exocrine tissue. To identify factors that are expressed in exocrine 
pancreas tissue and regulate proper endocrine development, we first compared the gene expression profiles of 
pancreatic tissue at P1 of control mice and Pdx1cKO mice. As shown in Supplementary Table S1, microarray 
analysis revealed that the expressions of many digestive enzymes including Ctrl (chymotrypsin-like-peptide) and 
Pnliprp2 (pancreatic lipase-related protein 2) were significantly reduced in Pdx1cKO pancreata, which is consist-
ent with the severely hypoplastic exocrine tissue of these mice. Among the genes showing reduced expression, we 
focused on Trefoil factor 2 (TFF2), which was previously reported to stimulate the proliferation of β cells in adult 
pancreas4, as a candidate factor responsible for the endocrine defects. A reduction of TFF2 mRNA expression in 
mutant pancreata at P1 was confirmed by RT-PCR analysis (Supplementary Fig. S1A). As for other genes of the 
TFF family, qPCR analyses showed similar expression levels of TFF1 mRNA and TFF3 mRNA in Pdx1cKO and 
control pancreata at P1 (Supplementary Fig. S1B).
Next, we analyzed the expression pattern of TFF2 in the pancreas. During normal pancreatic development, 
TFF2 mRNA was first expressed at E16.5 and increased as development proceeded (Fig. 1A,B). On the contrary, 
although TFF2 mRNA in the Pdx1cKO pancreata was also first expressed at E16.5, the expression was much 
lower and it did not tend to increase with time (Fig. 1B). In normal mice, immunohistochemistry detected TFF2 
expression in the proximal and distal ductal structures and in developing acinar cells at E16.5 (Fig. 1C). At E18.5, 
however, while most acinar cells still expressed TFF2, the expression in the proximal ducts (trunk region) was 
reduced. Finally, strong immunostaining of TFF2 was maintained in acinar cells, but was almost undetectable 
in islets at P1. In Pdx1cKO mice, TFF2 was hardly detectable at any of the three stages except in proximal ducts, 
which were not affected by the Elastase-Cre recombination (Fig. 1C). Interestingly, in situ hybridization demon-
strated acinar-specific expression of TFF2 mRNA in adult pancreas (Supplementary Fig. S2), which is incon-
sistent with a previous report that showed TFF2 expression in adult islets by immunochemistry4. Based on our 
findings, we concluded that TFF2 is expressed in normal embryonic and adult pancreatic exocrine tissue, but 
significantly suppressed in the same tissue of Pdx1cKO mutants.
Accelerated apoptosis of embryonic Nkx6.1+ trunk cells and Insulin+ cells in Pdx1cKO mutant 
pancreata. Since the onset of TFF2 expression began at E16.5, we analyzed the endocrine phenotype of 
Pdx1cKO mice at this stage. We found that the numbers of Nkx6.1+ trunk cells, which are the origin of endo-
crine lineage, and Insulin+ cells were significantly reduced in mutants compared with control mice (Nkx6.1+ 
trunk cells: control, 894.4 ± 155.1 cells (n = 5), Pdx1cKO, 213.0 ± 41.1 cells (n = 5), p = 0.015; Insulin+ cells: 
control, 337.0 ± 36.6 cells (n = 3), Pdx1cKO, 158.3 ± 14.7 cells (n = 3), p = 0.042) (Fig. 2A,B). To account for 
this difference, we found accelerated apoptosis of Nkx6.1+ trunk cells and Insulin+ cells in the mutant mice 
(TUNEL-positive Nkx6.1+ trunk cells: control, 0.02 ± 0.01% (n = 4), Pdx1cKO, 3.25 ± 0.28% (n = 4), p = 0.002; 
TUNEL-positive Insulin+ cells: control, not detected (n = 3), Pdx1cKO, 1.13 ± 0.16% (n = 3), p = 0.028). In 
addition, while the proliferation rate of Nkx6.1+ trunk cells in mutant mice was almost the same as in con-
trol mice (pHH3-positive Nkx6.1+ trunk cells: control, 28.49 ± 5.21% (n = 5), Pdx1cKO, 26.09 ± 2.32% (n = 5), 
p = 0.21), that of Insulin+ cells was significantly less (pHH3-positive Insulin+ cells: control, 2.01 ± 0.21% (n = 3), 
Pdx1cKO, 1.03 ± 0.10% (n = 3), p = 0.043) (Fig. 2C,D).
TFF2 prevents apoptosis of embryonic insulin-expressing cells through CXCR4. Because pre-
vious studies identified CXCR4 as a functional receptor for TFF2 in β cell lines and submandibular gland5,6, we 
analyzed CXCR4 expression in embryonic pancreas. Our immunohistochemical analyses revealed that CXCR4 is 
restrictively expressed in Insulin+ cells at E16.5 in both control and mutant pancreata (Fig. 3).
To test the hypothesis that exocrine-driven TFF2 regulates endocrine development, we performed explant 
culture of pancreatic tissue at E16.5. In our culture condition, the exocrine and endocrine components were 
kept for 48 hours with dilatation of the pancreatic ducts (Supplementary Fig. S3). We found that the addition 
of mouse recombinant TFF2 (rTFF2) increased the number of Insulin+ cells in Pdx1cKO pancreata (no rea-
gents, 74.6 ± 8.8 cells (n = 7), rTFF2 300 nM, 128.9 ± 9.6 cells (n = 7), p = 0.0041), and that this elevation was 
antagonized by the addition of AMD31007, a specific inhibitor of CXCR4 (rTFF2 300 nM + AMD3100 100 μM, 
83.5 ± 11.4 cells (n = 4), p = 0.037) (Fig. 4A,B). While TFF2 did not stimulate the proliferation of Insulin+ cells 
in Pdx1cKO pancreata (pHH3-positive Insulin+ cells: control without reagents, 0.92 ± 0.38% (n = 3), Pdx1cKO 
without reagents, not detected (n = 4), Pdx1cKO with rTFF2 300 nM, not detected (n = 5)) (Fig. 4C,D), the TFF2/
CXCR4 axis prevented their apoptosis. Indeed, our TUNEL staining analyses revealed that TFF2 reduces the 
percentage of TUNEL + cells among Insulin+ cells in the explant culture of Pdx1cKO pancreata and that this 
reduction was negated by ADM3100 treatment (no reagents, 5.89 ± 0.67% (n = 3), rTFF2 300 nM, 2.57 ± 0.75% 
(n = 7), rTFF2 300 nM + AMD3100 100 μM, 6.99 ± 1.08% (n = 4), p = 0.046 (no reagents vs. rTFF2), p = 0.018 
(rTFF2 vs. rTFF2 + AMD3100)) (Fig. 4E,F). The anti-apoptotic effect of the TFF2/CXCR4 axis was confirmed by 
the explant culture of normal pancreata, in which we found that the percentage of TUNEL-positive cells among 
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Insulin+ cells was significantly increased by AMD3100 treatment (no reagents, 2.19 ± 0.34% (n = 3), AMD3100 
100 μM, 7.58 ± 0.16% (n = 3), p = 0.0017) (Fig. 4G,H). Taken together, TFF2 expressed in exocrine cells from 
E16.5 functions to preserve embryonic Insulin+ cells via CXCR4 in normal development. In Pdx1cKO mice, 
on the other hand, the poor TFF2 expression caused accelerated apoptosis of embryonic Insulin+ cells, which 
resulted in fewer Insulin+ cells and ultimately the diabetic phenotype after birth.
Figure 1. Elastase-Cre-mediated Pdx1 inactivation reduces acinar TFF2 in embryonic and neonatal pancreas. 
(A) The expression of TFF2 was detected by RT-PCR in control mice pancreas from E16.5. The original data 
are shown in Supplementary Fig. S1C. (B) Expression of TFF2 is significantly less in Pdx1cKO mice (red) than 
in control mice (blue). (control mice: n = 7 at E14.5, n = 5 at E16.5, n = 5 at E18.5, and n = 7 at P1; Pdx1cKO 
mice: n = 5 at E14.5, n = 6 at E16.5, n = 6 at E18.5, and n = 7 at P1; p = N.D at E14.5, p = 0.041 at E16.5, 
p = 0.0065 at E18.5 and p = 0.0040 at P1). Note that the expression of TFF2 in the mutant stomach is equivalent 
to that in control stomach at P1 (right panel) (control mice, n = 3, Pdx1cKOmice, n = 3, p = 0.68122). (C) 
Immunostaining of TFF2. TFF2 expression was detected in exocrine cells including the proximal (dotted lines) 
and distal ducts and acinar cells, but not in islets (arrows) in control mice (upper panels). In Pdx1cKO mice, 
TFF2 expression was hardly detectable except in the proximal ducts (dotted lines), which were not recombined 
by Elastase-Cre (bottom panels). These expression patterns were confirmed in at least three individual mice for 
both genotypes. Scale bars, 100 μm. Bars represent the mean value ± SE. *p < 0.05, **p < 0.01.
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TFF2 has an anti-apoptotic effect on Nkx6.1+ trunk cells through an unknown receptor in 
Pdx1cKO pancreata. As mentioned above, Pdx1cKO mice had significantly fewer Nkx6.1+ cells than con-
trol mice at E16.5 along with accelerated apoptosis (Fig. 2). In the tissue explant culture experiments, we noticed 
Figure 2. Reduced number and accelerated apoptosis of Nkx6.1-positive cells and insulin-producing cells at 
E16.5 in Pdx1cKO mice. (A) Immunostaining of Nkx6.1 (green), insulin (red) and DAPI (blue) in control (left 
panels) and Pdx1cKO (right panels) pancreata at E16.5. (B) Quantitative analysis revealed that the numbers 
of Nkx6.1+ cells (upper panel) and Insulin+ cells (bottom panel) in Pdx1cKO mice (red) are significantly less 
than in control mice (blue) at E16.5. (C) TUNEL and pHH3 analyses of E16.5 pancreata. Yellow arrowheads 
show TUNEL- or pHH3-positive cells in Nkx6.1+ or Insulin+ cells. (D) Quantitative analyses show that the 
apoptosis rates of Nkx6.1+ cells and Insulin+ cells were significantly higher in Pdx1cKO pancreata (red) 
compared to control pancreata (blue) (left two panels). The proliferation rate of Nkx6.1+ cells was equivalent, 
but that of Insulin+ cells was less in Pdx1cKO pancreata (right two panels). Scale bars, 100 μm. Bars represent 
the mean ± SE. *p < 0.05, **p < 0.01.
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that TFF2 significantly increased the number of Nkx6.1+/Insulin- trunk cells in mutant pancreata, but that the 
addition of AMD3100 did not affect this elevation, which is consistent with the undetectable CXCR4 expres-
sion in this cell type (no reagents, 103.3 ± 13.7 cells (n = 4), rTFF2 300 nM, 179.8 ± 18.1 cells (n = 5), rTFF2 
300 nM + AMD3100 100 μM, 176.7 ± 18.4 cells (n = 3), p = 0.044 (no reagents vs. rTFF2), p = 0.99 (rTFF2 vs. 
rTFF2 + AMD3100)) (Fig. 5A,B). Again, TFF2 had an anti-apoptotic effect on Nkx6.1+/Insulin- trunk cells, 
as shown by the reduced percentage of TUNEL + cells (no reagents, 12.10 ± 1.40% (n = 3), rTFF2 300 nM, 
1.55 ± 0.18% (n = 3), p = 0.022) (Fig. 5C,D). Therefore, we concluded that TFF2 functions to preserve Nkx6.1+ 
endocrine precursor cells through an unknown receptor in Pdx1cKO pancreata.
Discussion
Rising evidence supports the notion that exocrine-driven factors regulate endocrine islets in adult pancreas. 
Evidence includes reports that found Reg1 stimulates β cell proliferation in a rat regeneration model8, exocrine 
tissue extracts in a pancreatic-duct-ligated model (PDL model) induce β cell de-differentiation in vitro9, and 
Sostdc1 functions to orchestrate insulin secretion and glucose homeostasis under metabolic stress10. These factors 
are activated in response to tissue injury or metabolic stress of the adult pancreas, but the molecular basis of the 
exocrine-endocrine interaction during embryonic organogenesis is unknown. In the present study, we identi-
fied TFF2 as a novel exocrine-driven factor that protects endocrine-lineage cells against apoptosis in embryonic 
pancreas.
TFF2 was first identified in the pancreas of adult porcine11, and its expression has since been reported in sev-
eral other organs including gastrointestinal tract12,13, immune cells14–16, lung17,18, kidney19 and skin20. Conflicting 
reports have prevented determination of the precise localization of TFF2 in the pancreas. Jackerott et al. demon-
strated TFF2 mRNA expression in isolated human adult islets21, but that paper along with Madsen et al. reported 
no TFF2 protein expression in the acinar or islet cells of adult human pancreas22. In mice, Orime et al. showed 
TFF2 expression in adult β cells4, but Masui et al. reported by RNA-seq analyses that TFF2 expression was 
reduced in Rbpjl KO mice at E17.523. Since Rbpjl is an indispensable compartment of the pancreas Transcription 
Factor 1 complex in acinar cells, they regarded TFF2 as an exocrine gene at this stage. We show in the present 
study by a more comprehensive analysis than previous works that TFF2 is expressed in exocrine cells but not in 
islet cells from E16.5. Seeing that our findings are consistent with the majority of previous papers, it would seem 
TFF2 protein is not expressed in adult islet cells.
A cell-protective function by TFF2 has been well documented in the stomach. TFF2 is expressed in the 
mucous neck cells of fundic glands and in the basal cells of the antral and pyloric glands and Brunner’s gland in 
duodenum12,13, and secreted TFF2 is believed to stabilize the mucous barrier that physically protects epithelial 
cells from acid-induced ulcerations24. TFF2 deficiency increases susceptibility to indomethacin-induced ulcer-
ations in mice25, and the oral administration of TFF2 ameliorated ulcerations in TFF2 deficient rat26. However, 
because the subcutaneous injection of TFF2 also ameliorated ulcerations, it would seem this protein’s protective 
function is direct. Indeed, the anti-apoptotic effect of TFF2 was shown in vitro in several cancer cell lines: recom-
binant TFF2 reduced the apoptosis of MCF-7 and T47D breast carcinoma cell lines, and the addition of anti-TFF2 
hSP3 accelerated the apoptosis of LS174T and SW480 colorectal carcinoma cell lines27. Here, we used explant cul-
ture experiments of embryonic pancreatic tissue to show that TFF2 prevents the apoptosis of embryonic Insulin+ 
cells through CXCR4. Furthermore, we showed that TFF2 exerts an anti-apoptotic effect on Nkx6.1+ trunk cells 
in Pdx1cKO mice, though the interacting receptor was unidentified. Thus, the hyper-activated apoptosis of endo-
crine lineage in Pdx1cKO mice can be explained by a lack of exocrine-driven TFF2. In addition, considering that 
TFF2 increases ERK1/2 phosphorylation and stimulates the proliferation of MIN6 cells and isolated adult murine 
islet4, TFF2 could be involved, at least in part, in the postnatal expansion of endocrine mass, which is extremely 
Figure 3. Expression of CXCR4 in insulin-expressing cells. Immunostaining of CXCR4 (green), insulin (red) 
and DAPI (blue) in control (upper panels) and Pdx1cKO (bottom panels) mice at E16.5. Note that CXCR4 
expression is restricted to Insulin+ cells in both mice. Scale bars, 100 μm.
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Figure 4. TFF2 prevents apoptosis of embryonic insulin-expressing cells through CXCR4. Explant culture 
of E16.5 pancreatic tissue for 48 hours. (A) Immunostaining of insulin (red), beta-catenin (green) and DAPI 
(blue) for the cultured explant without reagents (left panel), with rTFF2 (middle panel) and with rTFF2 plus 
AMD3100 (right panel). (B) Quantitative analysis of the number of Insulin+ cells. (C) Immunostaining of 
pHH3 (green), insulin (red) and DAPI (blue) for cultured control explant (left panel) and for Pdx1cKO explant 
without and with rTFF2 (middle and right panels, respectively). The yellow arrowhead shows pHH3-positive 
Insulin+ cells. (D) Quantitative analyses of Insulin+ cell proliferation. (E) Immunostaining of TUNEL (green), 
insulin (red) and DAPI (blue) for cultured Pdx1cKO explant without reagents (left panel), with rTFF2 (middle 
panel) and with rTFF2 plus AMD3100 (right panel). Yellow arrowheads show TUNEL-positive Insulin+ cells. 
(F) Quantitative analysis of Insulin+ cell apoptosis in Pdx1cKO explant. In control mice pancreas, CXCR4 
protected Insulin+ cells from apoptosis. (G) Immunostaining of TUNEL (green), insulin (red) and DAPI (blue) 
for the control explant without and with AMD3100 (left and right panels, respectively). Yellow arrowheads show 
TUNEL-positive Insulin+ cells. (H) Quantitative analyses of Insulin+ cell apoptosis. Scale bars, 100 μm. Bars 
represent the mean value ± SE. *p < 0.05, **p < 0.01.
www.nature.com/scientificreports/
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poor in the mutant mice3. At the same time, there exists endocrine defects in Pdx1cKO mice that cannot be 
explained by TFF2. For example, a previous study reported the numbers of Nkx6.1+ trunk cells, Ngn3+ endo-
crine precursors and Insulin+ cells are were reduced in the mutants as early as E14.53, which is before the onset 
of TFF2 expression (E16.5). The identification of other exocrine-driven factors would deepen our understanding 
of how exocrine-endocrine interactions contribute to the development of endocrine pancreas.
Methods
Mice. To obtain Pdx1-conditional knock-out mice, Pdx1loxP mice28 and Elastase-Cre mice29 were interbred as 
our previous report3. All animal experiments were performed in accordance with the Kyoto University guidelines 
for animal experiments and approved by the animal research committee of Kyoto University.
Genotyping. DNA from the tail tips of mice was genotyped by PCR with the following primer sets: 1) 
Cre (forward) 5′-CGTACTGACGGTGGGAGAAT-3′ and (reverse) 5′-CCCGGCAAAACAGGTAGTTA-3′, 
product size 166 bp; and 2) Pdx1loxP (forward) 5′-GGCTATCCACTCCTGCTCTG-3′ and (reverse) 
5′-AGGTGGGTTCGCTAAACCTT-3′, product size 271 bp and 305 bp from WT and floxed alleles, respectively.
Microarray analyses. Pancreata were dissected from postneonatal day 1 (control mice, n = 2, Pdx1cKO 
mice, n = 3) and immediately submerged in RNAlater (Ambion, Inc., Austin, TX). 250 ng of total RNA pre-
pared with RNeasy Micro Kit (QIAGEN) was subjected to cDNA synthesis with GeneChip WT Expression Kit 
(Ambion), and the resultant cDNA was fragmented and hybridized to Mouse Gene 1.0 ST Array (Affymetrix). 
After hybridization, GeneChip arrays were washed and stained by GeneChip Fluidics Station 450 (Affymetrix) 
and detected by Scanner 3000 TG system (Affymetrix) according to the manufacturer’s instructions. Data analy-
ses were performed with GeneSpringGX 12.1 software (Agilent Technologies). Microarray data have been depos-
ited in Gene Expression Omnibus under accession number GSE118665.
RNA isolation and Rt-pCR. Total RNA was extracted using the RNeasy Mini Kit (Qiagen). First-strand 
cDNA synthesis was performed using Rever Tra Ace qPCR RT Master Mix (Toyobo). Quantitative RT-PCR was 
performed with SYBR Green. The primer sequences are listed in Supplementary Table S4. Independent experi-
ments were performed three times and confirmed. Data were normalized in relation to the expression of GapDH. 
The analysis was performed using ΔΔCt methods.
Tissue Preparation for Paraffin Sections. Tissue preparation and paraffin sections were performed as 
previously described30.
Figure 5. Nkx6.1-positive trunk cells are affected by TFF2. Analyses of Nkx6.1+/Insulin- trunk cells in explant 
culture experiments. (A) Immunostaining of Nkx6.1 (green) and insulin (red) for cultured Pdx1cKO explant 
without reagents (left panel), with rTFF2 (middle panel) and with rTFF2 plus AMD3100 (right panel). (B) 
Quantitative analyses of the number of Nkx6.1+/Insulin- trunk cells. (C) TUNEL staining of cultured Pdx1cKO 
explant without and with rTFF2 (left and right panels, respectively). (D) Quantitative analyses of Nkx6.1+/
Insulin- trunk cell apoptosis. Scale bars, 100 μm. Bars represent the mean value ± SE. *p < 0.05.
www.nature.com/scientificreports/
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Immunohistochemistry and immunofluorescence. Paraffin sections were cut into 4 μm thick slices. 
After rehydration, slides were washed and incubated for 30 min at room temperature with Protein Block (Dako) 
followed by overnight incubation at 4 °C with primary antibodies (Supplementary Table S2). The sections were 
washed in phosphate-buffered saline (PBS) and incubated for 60 min with secondary antibodies (Supplementary 
Table S3). Images were taken with a BZ-9000E HS All-in-one Fluorescence Microscope (Keyence).
In situ hybridization. A digoxigenin-labeled RNA probe specific for murine TFF2 was transcribed with 
digoxigenin-11-UTP according to the manufacturer’s instructions (Roche, Basel, Switzerland) by PCR using the 
primers 5′-CCTGCTGGCAGTGGTCCT-3′ and 5′-CAGACTGTGGGAAGAAACACC-3′. In situ hybridization 
was performed as described previously31. The alkaline phosphatase chromogen reaction was performed using 
Fast Red (Roche) as the substrate at room temperature for 48 hours. The sections were then washed with distilled 
water and mounted on glass slides in mounting medium. Control specimens for in situ hybridization (#SMPS-36, 
#SMPS-29) were obtained from 8 week-old C57BL/6 mice, which were purchased from GenoStaff (Tokyo, JPN).
PHH3 staining and TUNEL assays. Mitotic activity was analyzed by immunolabeling with rabbit 
anti-phospho-Histone H3 (Ser10) (Millipore). TUNEL assays were done using the DeadEnd Fluorometric system 
(Promega) according to the manufacturer’s instructions.
explant culture. We obtained pancreata explant from control and Pdx1cKO mice at E16.5. Pancreata 
explants were cultured in DMEM/Ham F-12 (Invitrogen) containing 1% L-glutamine, 10% fetal bovine serum 
(FBS) and 0.5% penicillin-streptomycin (Invitrogen). Pancreata explants were cultured with a 24-well Ultra Low 
Attachment Surface plate (Costar) for 48 hours.
Reagents. Recombinant mouse TFF2 (#RPA748MU01) was purchased from Uscn Life Science (Texas, USA). 
AMD3100 (#AB120718) was purchased from Abcam (Cambridge, GBD).
Cell Counting. To evaluate cell numbers in pancreas tissue at E16.5, the whole pancreas was sectioned in 
4 μm intervals, and the number of Insulin+ cells was counted every 150 μm. To evaluate the cell numbers on 
pancreata explant in vitro, the whole explant was sectioned in 4 μm intervals, and the number of Insulin- or 
Nkx6.1-positive cells was counted every 100 μm. Microscopic observation was performed at 200x magnification.
statistical analysis. All statistical analyses were performed using Student’s t-tests or one-way analysis of 
variance (ANOVA) implemented in JMP Pro 14 Software (SAS Institute, Cary, NC, USA) to evaluate differences 
between groups. A value of P < 0.05 was considered to indicate a statistically significant difference.
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